ClinicalTrialExchange
  • Home
  • For Patients
  • For Professionals
  • About
  • Contact

Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Vaso-Occlusive Crises

  • Lidocaine for Opioid Sparing in Vaso-occlusive Crisis of Sickle Cell Disease
  • Morphine Clearance and Glomerular Filtration in Sickle Cell Patients in Crisis in Intensive Care
  • Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
  • Efficacy of Liberal Versus Restricted IV Fluid Approach in the Management of Sickle Cell Vaso-Occlusive Crisis
  • A Study of Intravenous L-Citrulline in Patients Aged 6-21 Years Old With Sickle Cell Disease Presenting to Emergency Departments in Acute Vaso-Occlusive Crisis
  • Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
  • Ketorolac for Acute Vaso-Occlusive Crisis in Pediatric Sickle Cell Disease
  • A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
  • Analgesic Effect of Parecoxib Versus Morphine in SCD Patients Presenting to the Emergency Department
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies

Clinical Trials data from clinicaltrials.gov

Powered by DrugPatentWatch.

  • About
  • Contact
  • Follow ClinicalTrialsExchange:

      ClinicalTrialsExchange Linkedin Group